The Effect Of Motıvatıonal Intervıewıng On Cancer Fear And Partıcıpatıon In Cervıcal Cancer Screenıngs Among Women Lıvıng In Rural Areas

April 17, 2026 updated by: Ozge Aslan Koyutürk

The Effect Of A Motıvatıonal Intervıew Based Nursıng Care Program On Health Belıefs And Fear Of Cancer Related To Cervıcal Cancer And Screenıng In Rural Women: A Randomızed Controlled Study

This research was conducted to determine the effect of a motivational interview-based nursing care program on health beliefs and cancer fears related to cervical cancer and screening in rural women.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study will investigate the effect of motivational interviewing on cancer screening participation and cancer fear, and includes a control and an intervention group. The study is a single-blind randomized trial.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The individual must be registered with the Sivaslı Community Health Center affiliated with the Uşak Provincial Health Directorate
  • Reside in a rural area
  • Be within the age range (30-65) suitable for the national screening program
  • Have an intellectual disability.

Exclusion Criteria:

  • Having a condition that prevents communication (unable to speak or understand Turkish, having a speech disorder)
  • being illiterate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motivational Interviewing
The motivational interviewing group will receive a total of four Motivational Interviewing-Based Nursing Care Programs, with women receiving one program per week. The control group will receive no intervention.
Behavioral: motivational interview
A total of four motivational meetings, one per week.
Experimental: control
No intervention will be made against the control group.
Behavioral: motivational interview
A total of four motivational meetings, one per week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of motivational interviewing on health beliefs regarding cervical cancer and Pap smear
Time Frame: From baseline to 4 weeks
Health beliefs will be assessed using the Cervical Cancer and Pap Smear Test Health Belief Model Scale.
From baseline to 4 weeks
power calcilation
Time Frame: from registration until the end of the 4-week period
"The sample size was calculated based on an effect size of 0.794, with 95% power and α=0.05. n:80"
from registration until the end of the 4-week period
Effect of motivational interviewing on cancer anxiety
Time Frame: From baseline to 4 weeks
Cancer anxiety will be measured using the Cancer Anxiety Scale.
From baseline to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ozge Aslan Koyutürk

Investigators

  • Study Director: Öznur KÖRÜKCÜ, PROFESSOR, Akdeniz University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 27, 2026

Primary Completion (Estimated)

August 2, 2026

Study Completion (Estimated)

September 2, 2026

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

April 17, 2026

First Posted (Actual)

April 21, 2026

Study Record Updates

Last Update Posted (Actual)

April 21, 2026

Last Update Submitted That Met QC Criteria

April 17, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TBAEK-355

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

all collected IPD

Study Data/Documents

  1. Study Protocol
    Information comments: PubMed

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fear

Clinical Trials on motivational interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe